Opioid receptor modulator dosage formulations

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 12097187
APP PUB NO 20230293493A1
SERIAL NO

18324449

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Abuse deterrent solid dosage formulations containing 5-({[2-Amino-3-(4-carbamoyl-2,6 -dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1H-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy -benzoic acid, and processes for the preparation and administration of these formulations.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALLERGAN HOLDINGS UNLIMITED COMPANYCLONSHAUGH BUSINESS & TECHNOLOGY PARK DUBLIN 17

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Andrae, David Austin, US 4 20
Costello, Tim Rockville, US 13 101
Covington, Paul Wilmington, US 12 135
Davenport, J Michael Rockmart, US 1 0
Dove, Leonard Scott Driftwood, US 1 0
McIntyre, Gail Lansdale, US 6 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 24, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 24, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 24, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00